News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Endocyte, Inc. (ECYT) Announces Poster Presentations on Vintafolide and Etarfolatide at the 2013 Annual Meeting of the American Society of Clinical Oncology


5/31/2013 9:47:09 AM

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

WEST LAFAYETTE, Ind., May 30, 2013 (GLOBE NEWSWIRE) -- Endocyte, Inc. (Nasdaq:ECYT), a biopharmaceutical company developing targeted small molecule drug conjugates (SMDCs) and companion imaging diagnostics for personalized therapy in cancer and other serious diseases, today announced that the company's investigational cancer candidate, vintafolide (EC145) and its non-invasive, companion diagnostic imaging agent, etarfolatide (EC20) will be featured at the 2013 Annual Meeting of the American Society of Clinical Oncology (ASCO) to be held in Chicago, May 31 to June 4.

Help employers find you! Check out all the jobs and post your resume.

Read at GlobeNewswire

Related News

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES